Katabi Maha's Insider Trades & SAST Disclosures
Katabi Maha's most recent trade in Aerovate Therapeutics Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Katabi Maha.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 21 Mar 2024 | 413,450 | 3,133,987 | - | 40.5 | 16,748,860 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 40.50 per share. | 21 Mar 2024 | 340,000 | 2,793,987 | - | 40.5 | 13,770,000 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 43.00 per share. | 21 Mar 2024 | 32,756 | 3,595,690 | - | 43 | 1,408,508 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 21 Mar 2024 | 21,918 | 3,573,772 | - | 44 | 964,392 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 46.18 per share. | 21 Mar 2024 | 13,718 | 3,547,437 | - | 46.2 | 633,497 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Sale of securities on an exchange or to another person at price $ 45.52 per share. | 21 Mar 2024 | 12,617 | 3,561,155 | - | 45.5 | 574,326 | Class A Common Stock |
| RayzeBio Inc. | Katabi Maha | Director | Sale or transfer of securities back to the company at price $ 62.50 per share. | 26 Feb 2024 | 1,209,764 | 0 | - | 62.5 | 75,610,250 | Common Stock |
| RayzeBio Inc. | Katabi Maha | Director | Sale or transfer of securities back to the company at price $ 62.50 per share. | 26 Feb 2024 | 1,209,764 | 0 | - | 62.5 | 75,610,250 | Common Stock |
| RayzeBio Inc. | Maha Katabi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 18,235 | 0 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Katabi Maha | Director | Purchase of securities on an exchange or from another person at price $ 31.00 per share. | 30 Jan 2024 | 161,290 | 3,628,446 | - | 31 | 4,999,990 | Class A Common Stock |
| Aerovate Therapeutics Inc | Katabi Maha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 3,519 | 3,519 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 2,627 | 2,627 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vera Therapeutics Inc - Or... | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 9,925 | 9,925 | - | - | Stock Option (right to buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 7,240 | 7,240 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | 01 Jul 2021 | 10,565,238 | 0 | - | - | Series A Preferred Stock | ||
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | 01 Jul 2021 | 3,401,544 | 3,401,544 | - | - | Common Stock | ||
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 01 Jul 2021 | 357,142 | 3,758,686 | - | 14 | 4,999,988 | Common Stock |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 2,467 | 2,467 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 8,082,190 | 10,565,238 | - | - | Series A Preferred Stock | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,164,213 | 2,483,048 | - | - | Series A Preferred Stock | |
| Aerovate Therapeutics Inc | Maha Katabi | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges